Info

BloodStream

BloodStream is an entertaining and informational podcast for the bleeding disorders community. Each week, hemophilia patient Patrick James Lynch and former non-profit director Amy Board are joined by advocacy leaders, medical experts, and other guests to discuss the latest news, scientific advancements, policy initiatives, and so much more. Subscribe wherever you listen, or search BloodStream Podcast on YouTube to catch every episode there. Produced by Believe Limited. Presenting sponsor: Takeda.
RSS Feed
BloodStream
2024
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Sep 17, 2021

During last month’s Bleeding Disorders Conference, Believe Limited’s Science Fair  hosted a session that provided a brief overview of the state of science in bleeding disorders, featuring NHF CEO Len Valentino alongside hematologists and researchers Dr. Robert Sidonio and Dr. Jonathan Roberts. Audio provided courtesy of the National Hemophilia Foundation.

 

Show Notes:

PRESENTING SPONSOR: Takeda

SCIENCE FAIR SPONSOR: Spark Therapeutics

Register for NHF's State of the Science Research Summit

NHF Education on Rare Bleeding Disorders

Emicizumab PUPs and Nuwiq ITI Study

VISIT The Science Fair

SUBSCRIBE to BloodStream on Apple Podcasts

CHECK OUT all our stuff

0 Comments
Adding comments is not available at this time.